pCMX IkB alpha M Citations (9)
Originally described in: Suppression of TNF-alpha-induced apoptosis by NF-kappaB.Van Antwerp DJ, Martin SJ, Kafri T, Green DR, Verma IM Science. 1996 Nov 1. 274(5288):787-9. PubMed Journal
Articles Citing pCMX IkB alpha M
| Articles |
|---|
| Hairless and NFkappaB form a positive feedback loop after UVB and TNFalpha stimulation. Casta A, Kim H, Luke CT, Bachelor MA, Engelhard A, Owens DM, Christiano AM. Photochem Photobiol. 2012 Sep-Oct;88(5):1173-83. doi: 10.1111/j.1751-1097.2012.01110.x. Epub 2012 Mar 28. PubMed |
| Nuclear factor kappaB-dependent regulation of angiogenesis, and metastasis in an in vivo model of thyroid cancer is associated with secreted interleukin-8. Bauerle KT, Schweppe RE, Lund G, Kotnis G, Deep G, Agarwal R, Pozdeyev N, Wood WM, Haugen BR. J Clin Endocrinol Metab. 2014 Aug;99(8):E1436-44. doi: 10.1210/jc.2013-3636. Epub 2014 Apr 23. PubMed |
| Myocardial NF-kappaB activation is essential for zebrafish heart regeneration. Karra R, Knecht AK, Kikuchi K, Poss KD. Proc Natl Acad Sci U S A. 2015 Oct 27;112(43):13255-60. doi: 10.1073/pnas.1511209112. Epub 2015 Oct 15. PubMed |
| Inhibition of NF-kappaB by deoxycholic acid induces miR-21/PDCD4-dependent hepatocelular apoptosis. M Rodrigues P, B Afonso M, L Simao A, M Borralho P, M P Rodrigues C, E Castro R. Sci Rep. 2015 Dec 1;5:17528. doi: 10.1038/srep17528. PubMed |
| NF-kappaB promotes leaky expression of adenovirus genes in a replication-incompetent adenovirus vector. Machitani M, Sakurai F, Wakabayashi K, Nakatani K, Shimizu K, Tachibana M, Mizuguchi H. Sci Rep. 2016 Jan 27;6:19922. doi: 10.1038/srep19922. PubMed |
| Suppression of Oncolytic Adenovirus-Mediated Hepatotoxicity by Liver-Specific Inhibition of NF-kappaB. Machitani M, Sakurai F, Wakabayashi K, Nakatani K, Tachibana M, Kato N, Fujiwara T, Mizuguchi H. Mol Ther Oncolytics. 2017 Oct 26;7:76-85. doi: 10.1016/j.omto.2017.10.003. eCollection 2017 Dec 15. PubMed |
| Epigenetic silencing of tumor suppressor Par-4 promotes chemoresistance in recurrent breast cancer. Mabe NW, Fox DB, Lupo R, Decker AE, Phelps SN, Thompson JW, Alvarez JV. J Clin Invest. 2018 Oct 1;128(10):4413-4428. doi: 10.1172/JCI99481. Epub 2018 Aug 27. PubMed |
| MEK5/ERK5 activation regulates colon cancer stem-like cell properties. Pereira DM, Gomes SE, Borralho PM, Rodrigues CMP. Cell Death Discov. 2019 Feb 11;5:68. doi: 10.1038/s41420-019-0150-1. eCollection 2019. PubMed |
| The GTPase KRAS suppresses the p53 tumor suppressor by activating the NRF2-regulated antioxidant defense system in cancer cells. Yang H, Xiang S, Kazi A, Sebti SM. J Biol Chem. 2020 Mar 6;295(10):3055-3063. doi: 10.1074/jbc.RA119.011930. Epub 2020 Jan 30. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.